Medical Device | November 17, 2021
Cipla launches Spirofy for early diagnosis of COPD
It is India’s first pneumotach based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder (COPD)
It is India’s first pneumotach based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder (COPD)
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
Cipla has reported consolidated financial results for the period ended September 30, 2021
Cipla is a leading global pharma company
Lilly will continue to maintain its existing operating model for the remaining portfolio of products
Over 61 per cent of pharmacists stated that they aim to improve their knowledge and medical skills while 76 per cent collaborated with healthcare players to improve the outcome for their patients
The agreement is to develop, manufacture and commercialise biosimilars for the global market.
It’s an AB-rated generic therapeutic version of Durezol
India business contributes to a stellar performance
Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana
Subscribe To Our Newsletter & Stay Updated
